Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

NCT00464893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastric Adenocarcinoma

Interventions

DRUG: Catumaxomab
DRUG: catumaxomab

Sponsor

Neovii Biotech